PDL BioPharma, Inc. (NASDAQ:PDLI)
CAPS Rating:
A biopharmaceutical company focused on discovering, developing and commercializing innovative therapies for severe or life-threatening illnesses.
A biopharmaceutical company focused on discovering, developing and commercializing innovative therapies for severe or life-threatening illnesses.
Recs
I think the royalties are the best position to be in, for the pharmaceutical plays.